Skip Navigation
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer

Association List

Go to page: 1 2 [Full Text] NextPage
Displaying Investigations 1 to 100 of 106 found
From 20 References


Asmann et al 2011, Nucleic Acids Res
  Adenocarcinoma Breast
FAM102A/CIZ1
t(9;9)(q34;q34)

Atak et al 2013, PLoS Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP214/ABL1
t(9;9)(q34;q34)
T-Lineage

Chen et al 2013, Genome Biol
  Adenocarcinoma Breast
LRRC8A/CCBL1
t(9;9)(q34;q34)

Edgren et al 2011, Genome Biol
  Adenocarcinoma Breast
NOTCH1/NUP214
t(9;9)(q34;q34)

Gu et al 2016, Nat Commun
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP214/ABL1
t(9;9)(q34;q34)
B-Lineage

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Liver
ABL1/PRDM12
t(9;9)(q34;q34)
  Adenocarcinoma Liver
ABL1/FUBP3
t(9;9)(q34;q34)
  Squamous cell carcinoma Lung
CAMSAP1/UBAC1
t(9;9)(q34;q34)
  Squamous cell carcinoma Unknown site
CAMSAP1/SDCCAG3
t(9;9)(q34;q34)
  Transitional cell carcinoma Bladder
CAMSAP1/RABL6
t(9;9)(q34;q34)
  Mesenchymal tumor, NOS Unknown site
CAMSAP1/LCN8
t(9;9)(q34;q34)
  Squamous cell carcinoma Uterus, cervix
DPH7/ZMYND19
t(9;9)(q34;q34)
  Adenocarcinoma Stomach
EDF1/DPP7
t(9;9)(q34;q34)
  Squamous cell carcinoma Uterus, cervix
EHMT1/GFI1B
t(9;9)(q34;q34)
  Adenocarcinoma Breast
EHMT1/ARRDC1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
ENG/AK1
t(9;9)(q34;q34)
  Malignant melanoma Skin
GLE1/SLC27A4
t(9;9)(q34;q34)
  Adenocarcinoma Oesophagus
NELFB/FBXW5
t(9;9)(q34;q34)
  Astrocytoma, grade I-II Brain
NELFB/EXD3
t(9;9)(q34;q34)
  Adenocarcinoma Uterus, corpus
NOTCH1/LCN10
t(9;9)(q34;q34)
  Adenocarcinoma Oesophagus
NSMF/ZMYND19
t(9;9)(q34;q34)
  Malignant epithelial tumor, special type Uterus, corpus
NUP188/TBC1D13
t(9;9)(q34;q34)
  Transitional cell carcinoma Bladder
NUP188/TMEM8C
t(9;9)(q34;q34)
  Adenocarcinoma Uterus, corpus
NUP188/SPTAN1
t(9;9)(q34;q34)
  Adenocarcinoma Lung
PNPLA7/SNAPC4
t(9;9)(q34;q34)
  Adenocarcinoma Liver
POMT1/PPAPDC3
t(9;9)(q34;q34)
  Adenocarcinoma Stomach
PPP2R4/CRAT
t(9;9)(q34;q34)
  Adenocarcinoma Stomach
PTGES2/CIZ1
t(9;9)(q34;q34)
  Adenocarcinoma Ovary
RABL6/TMEM141
t(9;9)(q34;q34)
  Malignant epithelial tumor, special type Uterus, corpus
RAPGEF1/MED27
t(9;9)(q34;q34)
  Adenocarcinoma Lung
RAPGEF1/TTF1
t(9;9)(q34;q34)
  Mesenchymal tumor, NOS Unknown site
RAPGEF1/REXO4
t(9;9)(q34;q34)
  Malignant melanoma Skin
RAPGEF1/ZMYND19
t(9;9)(q34;q34)
  Squamous cell carcinoma Unknown site
RXRA/PRRC2B
t(9;9)(q34;q34)
  Adenocarcinoma Liver
RXRA/WDR5
t(9;9)(q34;q34)
  Mesenchymal tumor, NOS Unknown site
SEC16A/RXRA
t(9;9)(q34;q34)
  Adenocarcinoma Stomach
SPTAN1/FPGS
t(9;9)(q34;q34)
  Adenocarcinoma Breast
TBC1D13/ODF2
t(9;9)(q34;q34)
  Adenocarcinoma Liver
TRAF2/MAMDC4
t(9;9)(q34;q34)
  Transitional cell carcinoma Bladder
TRAF2/CACNA1B
t(9;9)(q34;q34)
  Adenocarcinoma Liver
TSC1/SARDH
t(9;9)(q34;q34)
  Malignant melanoma Skin
VAV2/RXRA
t(9;9)(q34;q34)
  Embryonal nervous system tumor, special type Adrenal
VAV2/BRD3
t(9;9)(q34;q34)
  Diffuse large B-cell lymphoma
VAV2/FNBP1
t(9;9)(q34;q34)

Imielinski et al 2012, Cell
  Adenocarcinoma Lung
TUBB4B/NELFB
t(9;9)(q34;q34)

Kloosterman et al 2017, Cancer Res
  Adenocarcinoma Large intestine
TSC1/RAPGEF1
t(9;9)(q34;q34)

Liu et al 2016, EBioMedicine
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP214/ABL1
t(9;9)(q34;q34)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
ABL1/PRRC2B
t(9;9)(q34;q34)
B-Lineage

Liu et al 2017, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
EDF1/NOTCH1
t(9;9)(q34;q34)
T-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP214/ABL1
t(9;9)(q34;q34)
T-Lineage

Pintarelli et al 2016, Oncotarget
  Nonneoplastic epithelial disorder/lesion Lung
MED22/SURF6
t(9;9)(q34;q34)

Roberts et al 2012, Cancer Cell
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP214/ABL1
t(9;9)(q34;q34)
B-Lineage

Robinson et al 2011, Nat Med
  Adenocarcinoma Breast
SEC16A/NOTCH1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
NOTCH1/SNHG7
t(9;9)(q34;q34)
  Adenocarcinoma Breast
NOTCH1+
t(9;9)(q34;q34)

Sato et al 2013, Nat Genet
  Adenocarcinoma Kidney
C9ORF114/CCBL1
t(9;9)(q34;q34)

Seki et al 2017, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP214/ABL1
t(9;9)(q34;q34)
T-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
SEC16A/NOTCH1
t(9;9)(q34;q34)
T-Lineage

Shah et al 2013, BMC Genomics
  Astrocytoma, grade III-IV/Glioblastoma Brain
VAV2/NOTCH1
t(9;9)(q34;q34)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Thyroid
SEC16A/NOTCH1
t(9;9)(q34;q34)
  Adenocarcinoma Thyroid
ZMYND19/ARRDC1
t(9;9)(q34;q34)
  Adenocarcinoma Thyroid
NUP188/PHYHD1
t(9;9)(q34;q34)
  Adenocarcinoma Prostate
EHMT1/GRIN1
t(9;9)(q34;q34)
  Adenocarcinoma Prostate
TSC1/CEL
t(9;9)(q34;q34)
  Adenocarcinoma Ovary
GLE1/ODF2
t(9;9)(q34;q34)
  Adenocarcinoma Ovary
CAMSAP1/KCNT1
t(9;9)(q34;q34)
  Adenocarcinoma Ovary
SLC25A25/CIZ1
t(9;9)(q34;q34)
  Squamous cell carcinoma Lung
ABL1/CCBL1
t(9;9)(q34;q34)
  Squamous cell carcinoma Lung
EXD3/PNPLA7
t(9;9)(q34;q34)
  Squamous cell carcinoma Lung
INPP5E/SEC16A
t(9;9)(q34;q34)
  Adenocarcinoma Lung
FAM102A/PTGES2
t(9;9)(q34;q34)
  Adenocarcinoma Lung
UBAC1/QSOX2
t(9;9)(q34;q34)
  Adenocarcinoma Lung
WDR34/ZER1
t(9;9)(q34;q34)
  Adenocarcinoma Lung
PRRC2B/NUP214
t(9;9)(q34;q34)
  Adenocarcinoma Lung
POMT1/NUP214
t(9;9)(q34;q34)
  Astrocytoma, grade I-II Brain
GPSM1/NUP214
t(9;9)(q34;q34)
  Adenocarcinoma Kidney
PNPLA7/DPH7
t(9;9)(q34;q34)
  Squamous cell carcinoma Oral cavity
DNM1/LCN2
t(9;9)(q34;q34)
  Squamous cell carcinoma Oral cavity
TSC1/DOLPP1
t(9;9)(q34;q34)
  Squamous cell carcinoma Oral cavity
ABL1/EXOSC2
t(9;9)(q34;q34)
  Squamous cell carcinoma Oral cavity
SETX/TTF1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
PPP2R4/FAM73B
t(9;9)(q34;q34)
  Adenocarcinoma Breast
NUP214/AIF1L
t(9;9)(q34;q34)
  Adenocarcinoma Breast
DOLPP1/TBC1D13
t(9;9)(q34;q34)
  Adenocarcinoma Breast
COQ4/DNM1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
ZER1/TBC1D13
t(9;9)(q34;q34)
  Adenocarcinoma Breast
PHYHD1/ZER1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
DPH7/PPP2R4
t(9;9)(q34;q34)
  Adenocarcinoma Breast
DDX31/AK8
t(9;9)(q34;q34)
  Adenocarcinoma Breast
ABL1/ADAMTSL2
t(9;9)(q34;q34)
  Adenocarcinoma Breast
LRRC8A/CCBL1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
PRRC2B/SET
t(9;9)(q34;q34)
  Adenocarcinoma Breast
PHYHD1/LRRC8A
t(9;9)(q34;q34)
  Adenocarcinoma Breast
SPTAN1/GLE1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
FAM102A/NAIF1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
ASS1/NCS1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
PPP2R4/NUP188
t(9;9)(q34;q34)
  Adenocarcinoma Breast
DOLPP1/SPTAN1
t(9;9)(q34;q34)
  Adenocarcinoma Breast
FAM129B/SEC16A
t(9;9)(q34;q34)
  Adenocarcinoma Breast
FAM129B/OLFM1
t(9;9)(q34;q34)

NextPage